ATE491720T1 - Impfstoff gegen pasteurella multocida - Google Patents

Impfstoff gegen pasteurella multocida

Info

Publication number
ATE491720T1
ATE491720T1 AT05857856T AT05857856T ATE491720T1 AT E491720 T1 ATE491720 T1 AT E491720T1 AT 05857856 T AT05857856 T AT 05857856T AT 05857856 T AT05857856 T AT 05857856T AT E491720 T1 ATE491720 T1 AT E491720T1
Authority
AT
Austria
Prior art keywords
pasteurella multocida
vaccine against
bacteria
against pasteurella
vaccines
Prior art date
Application number
AT05857856T
Other languages
English (en)
Inventor
Yugang Luo
Paul Vermeij
Antonius Jacobs
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE491720T1 publication Critical patent/ATE491720T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT05857856T 2004-12-22 2005-12-21 Impfstoff gegen pasteurella multocida ATE491720T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63944704P 2004-12-22 2004-12-22
PCT/EP2005/056995 WO2006122586A1 (en) 2004-12-22 2005-12-21 Pasteurella multocida vaccine

Publications (1)

Publication Number Publication Date
ATE491720T1 true ATE491720T1 (de) 2011-01-15

Family

ID=36677027

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05857856T ATE491720T1 (de) 2004-12-22 2005-12-21 Impfstoff gegen pasteurella multocida

Country Status (14)

Country Link
US (1) US8309101B2 (de)
EP (1) EP1831248B1 (de)
JP (1) JP4981684B2 (de)
KR (1) KR20070092290A (de)
CN (1) CN101087803B (de)
AT (1) ATE491720T1 (de)
AU (1) AU2005331860B2 (de)
BR (1) BRPI0519381A2 (de)
CA (1) CA2591624A1 (de)
DE (1) DE602005025404D1 (de)
MX (1) MX2007007570A (de)
RU (1) RU2415926C2 (de)
WO (1) WO2006122586A1 (de)
ZA (1) ZA200705087B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080241192A1 (en) * 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
CN101948791A (zh) * 2010-09-21 2011-01-19 华东理工大学 一种溶藻弧菌野生毒株的无标记基因缺失减毒突变株、相关制剂及应用
RU2455024C1 (ru) * 2010-12-30 2012-07-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи Министерства здравоохранения и социального развития РФ" Аттенуированные бактерии bordetella pertussis, вакцина против возбудителя коклюша
RU2460791C1 (ru) * 2011-07-28 2012-09-10 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Способ аттенуации вакцинного туляремийного штамма
US20140147475A1 (en) * 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
AU2014234452B2 (en) 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
EP3062816B1 (de) 2013-11-01 2020-08-05 Boehringer Ingelheim Animal Health USA Inc. Attenuierte pasteurella-multocida-impfstoffe und verfahren zur herstellung und verwendung davon
CN104560854B (zh) * 2015-01-07 2018-03-02 四川农业大学 缺失phoP的禽多杀性巴氏杆菌减毒菌株及其构建方法和应用
CN106114241A (zh) * 2016-06-28 2016-11-16 无锡新大力电机有限公司 一种含有冷却水套的太阳能电动汽车
CN109847060A (zh) * 2019-04-19 2019-06-07 黑龙江八一农垦大学 牛多杀性巴氏杆菌病、溶血性曼氏杆菌病二联灭活疫苗及其制备方法
CN110205395A (zh) * 2019-06-17 2019-09-06 武汉科前生物股份有限公司 副猪嗜血杆菌的血清分型方法、引物组合以及pcr体系

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0668779A4 (de) * 1992-11-06 1996-08-21 Univ Minnesota Impstoff zum Shutz gegen Pasteurellose - Infektion durch P.multocida.
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
EP1350796B1 (de) * 2002-04-05 2009-01-07 Merial Attenuirte Gram-negative Bakterien
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
JP2004242608A (ja) * 2003-02-17 2004-09-02 Nitsuseiken Kk 無毒変異型パスツレラ・ムルトシダ毒素とその遺伝子および製法
UA65107A (en) * 2003-05-30 2004-03-15 Vasyl Petrovych Ryzhenko Pasteurella multocida "z-40/155" strain for production of vaccine against pasteurellosis of livestock

Also Published As

Publication number Publication date
CN101087803B (zh) 2012-01-18
ZA200705087B (en) 2008-08-27
US20100062017A1 (en) 2010-03-11
WO2006122586A1 (en) 2006-11-23
BRPI0519381A2 (pt) 2009-01-20
CN101087803A (zh) 2007-12-12
US8309101B2 (en) 2012-11-13
CA2591624A1 (en) 2006-11-23
DE602005025404D1 (de) 2011-01-27
EP1831248A1 (de) 2007-09-12
AU2005331860B2 (en) 2011-08-11
EP1831248B1 (de) 2010-12-15
JP4981684B2 (ja) 2012-07-25
JP2008523840A (ja) 2008-07-10
MX2007007570A (es) 2007-07-24
KR20070092290A (ko) 2007-09-12
AU2005331860A1 (en) 2006-11-23
RU2007128047A (ru) 2009-01-27
RU2415926C2 (ru) 2011-04-10

Similar Documents

Publication Publication Date Title
ZA200705087B (en) Pasteurella multocida vaccine
EA201070794A1 (ru) Рекомбинантные антигены rsv
CY1113738T1 (el) Εμβολια κατα της γριπης χαμηλης περιεκτικοτητας σε προσθετα
WO2011073215A3 (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
MX2021001659A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
AR061246A1 (es) Anticuerpos anti- dill4 y metodos que los usan
ATE426412T1 (de) Adjuvante influenza-vakzine
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
BRPI0520330B8 (pt) adjuvante a base de ácido polinosínico-policitidílico
MX2009008928A (es) Composiciones que comprenden conjugados de polisacaridos y su uso como vacunas.
CY1116904T1 (el) Εμβολιο
BRPI0508064A (pt) flavivìrus, composição de vacina e molécula de ácido nucléico
TN2011000182A1 (en) Live, attentuated respiratory syncytial virus
WO2009059170A3 (en) Ehrlichia canis diva (differentiate infection from vaccinated animals)
AR059851A1 (es) Anticuerpos de la egfl7 y metodos de uso
WO2012079878A3 (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
PL404229A1 (pl) Wyizolowany immunogenny antygen bakteryjny i jego zastosowanie w profilaktyce i leczeniu zakażeń wywołanych przez Gram-ujemne bakterie
ATE413888T1 (de) Salmonella vakzine
MX2009003301A (es) Novedoso inmunogeno neutralizante (nimiv) de rhinovirus y su uso para aplicaciones de vacunas.
ATE535253T1 (de) Impfstoff gegen mycoplasma prrsv
ATE421695T1 (de) Immunogene glykopeptide zur diagnose von infektionen pathogener mikroorganismen
SG147465A1 (en) Vaccine
ATE424844T1 (de) Kombinationsvakzine für geflügel
ATE359815T1 (de) Streptococcus-phocae-vakzine
NZ591738A (en) Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties